Oncology
Two New Second-Line Options For Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Jean-Yves Douillard
Gordon McVie
REFERENCE: Abstracts: 6507 & 2LB, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
The vinca alkaloid vinflunine and the tyrosine kinase inhibitor gefitinib both achieved equivalent benefits to standard docetaxel second-line therapy among patients with advanced or metastatic non-small cell lung cancer previously treated with platinum.
JEAN-YVES DOUILLARD, Centre René Gauducheau, Nante
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
The vinca alkaloid vinflunine and the tyrosine kinase inhibitor gefitinib both achieved equivalent benefits to standard docetaxel second-line therapy among patients with advanced or metastatic non-small cell lung cancer previously treated with platinum.
John Crown
Lapatinib Adds Benefit to Capecitabine in Metastatic Breast Cancer
REFERENCE: Abstract: 2096, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOHN CROWN, St Vincent’s University Hospital, Dublin
In heavily pre-treated metastatic breast cancer, lapatinib has been confirmed to add a benefit to capecitabine, according to updated efficacy data presented in Barcelona. The implication is that gene profiles from some breast tumors could help pinpoint which patients might do best on lapatinib.
JOHN CROWN, St Vincent’s University Hospital, Dublin
In heavily pre-treated metastatic breast cancer, lapatinib has been confirmed to add a benefit to capecitabine, according to updated efficacy data presented in Barcelona. The implication is that gene profiles from some breast tumors could help pinpoint which patients might do best on lapatinib.
Rob Tollenaar
Gordon McVie
Gene Profile to Improve Recommendations in Stage II Colon Cancer?
REFERENCE: Abstract: 3007, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
ROB TOLLENAAR, Leiden University Medical Center
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
The ECCO conference heard that a gene expression profile could help doctors easily identify patients with stage II colon cancer who need chemotherapy after surgery, and might be better at selecting patients for chemotherapy than the current ASCO guidelines.
ROB TOLLENAAR, Leiden University Medical Center
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
The ECCO conference heard that a gene expression profile could help doctors easily identify patients with stage II colon cancer who need chemotherapy after surgery, and might be better at selecting patients for chemotherapy than the current ASCO guidelines.
To listen this episode please go to ASCO Audio Journal of Oncology in Advance Presentations.
Similar Interviews
Health For All 30 Years After Alma Ata? Mental Health And War»
AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
Two important symposia have been held in London to discuss healthcare issues posing significant dilemmas to world leaders in the 21st Century. "The Future of Primary Health Care" was attended by public health experts from around the Globe to assess the best options for improving primary health care in the future. It was held on the 30th anniversary of the Alma Ata Declaration made in 1977 which was intended as a blueprint for health provision and identified primary health care as the means through which the global goal of "Health for All" could be achieved. The second meeting, on "Mental Health in Fragile States", was held to raise the profile of mental health care in zones where conflict has taken place or is still happening. Analyses of the key issues and how to deal with them effectively were discussed by top experts from the London School of Hygiene and Tropical Medicine and associated organisations. Peter Goodwin attended both meetings and talked with some of the key speakers.AliaIbrahim Zai, Egbert Sondorp, Gill Walt, Lucy Gilson, Ravi Narayan, Richard Horton, Vikram Patel, Willem Van De Put
LSHTM Audio News: British Association Special Edition»
Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
Peter Goodwin hears from London School of Hygiene and Tropical Medicine experts speaking at the annual science festival of the British Association for the Advancement of Science held in Liverpool, September 6-10, 2008, and from recent scientific publications on: the health impact of global warming, a tropical virus reaching temperate zones, inequalities in cancer outcomes, how eating oily fish can save your eyesight, and free internet publishing scientific journals.Astrid Fletcher, Jo Lines, Sari Kovats, Colin Sutherland, Michel Coleman
© 2008 Audio Medica - Medical Audio News Interviews & Podcasts. 
Post a comment